16 Oct 2021

Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab

Read More
8 Oct 2021

Disposals of own shares

Read More
29 Sep 2021

New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress

Read More
24 Sep 2021

Disposals of own shares

Read More
10 Sep 2021

Disposals of own shares

Read More
6 Sep 2021

BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide

Read More
3 Sep 2021

Transparency notification Wellington

Read More
3 Sep 2021

Disposals of own shares

Read More
27 Aug 2021

Disposals of own shares

Read More
27 Aug 2021

UCB showcases commitment to treatment and management of epilepsy at the 34th International Epilepsy Congress

Read More
Subscribe to